TipRanks
Go Ultimate55% OFF

Chill Brands Group PLC (7HR0) AI Stock Analysis

DE:7HR0

Chill Brands Group PLC

(Frankfurt:7HR0)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Rapid Revenue GrowthThe sharp increase in annual revenue indicates that the company expanded sales substantially during the period. If this growth can be maintained and converted into positive gross profit, it could provide a larger base from which to improve operating performance and support future scale.
Negative Factors
Negative Equity and DebtNegative equity combined with meaningful debt indicates a severely weakened balance-sheet foundation. This reduces financial flexibility, increases leverage risk, and leaves fewer internal resources available to absorb ongoing losses or support operations without additional external funding.

Chill Brands Group PLC (7HR0) vs. iShares MSCI Germany ETF (EWG)

-75%-50%-25%0%25%50%DE:7HR0-66.67%EWG+5.90%Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 888.98K
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-0.0
Beta (1Y)
-8.86
Revenue Growth
―
EPS Growth
―
Country
Germany
Employees
11
Sector
Healthcare
Sector Strength
51
Industry
Drug Manufacturers - Specialty & Generic

Chill Brands Group PLC Business Overview & Revenue Model

Company Description

Chill Brands Group PLC, established in 2014, operates from its headquarters in London, United Kingdom. The company focuses on the innovation, manufacturing, and distribution of cannabidiol (CBD) consumer items and other lifestyle products across the...

Chill Brands Group PLC Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:7HR0 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:VLGGB:VLG71OutperformGBP 80.73M15.607.82%―――
GB:HLNGB:HLN63NeutralGBP 28.09B17.619.89%2.29%1.21%8.33%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
GB:PXSGB:PXS49NeutralGBP 18.77M-80.00-44.68%―-2.14%0.00%
GB:AGYGB:AGY42NeutralGBP 253.30M-4.04409.00%―2.94%-32.00%
GB:STXGB:STX42NeutralGBP 60.69M-7.7264.57%―36.19%60.75%

* Healthcare Sector Average

Performance Comparison

-50%0%50%100%150%DE:7HR0GB:AGYGB:PXSGB:STXGB:VLGGB:HLNJun '26Jul '26Aug '26Sep '26Oct '26
DE:7HR0 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:7HR0Chill Brands Group PLC0.01-0.02-66.67%
GB:AGYAllergy Therapeutics4.00-4.45-52.66%
GB:PXSProvexis plc0.800.2236.75%
GB:STXShield Therapeutics5.65-1.25-18.12%
GB:VLGVenture Life68.0014.5027.10%
GB:HLNHaleon PLC319.40-31.39-8.95%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.